Agree with NJ & Bunions but if it's massive dilution then scrap Phase III. The risk reward ain't worth it with this outfit at the helm. Remembering the CEO spouting over and over and over about Bellus Health being a "pure comparator and 500M market caps before Phase III and the biggie - Everybody wants in at Phase II.
Yeah, the CEO got none of that right.
Mackie Research wont even give the IPF/CC angle anything more than a 20 cent per share valuation.
That includes everything else in the pipeline.
Think about that.
They are basically saying the entire pipeline including DMT is trash.
The CEO ain't said jack about that in the Facebook Live webcast.
He's fine with letting Mackie Research trash the stock.
Christopher Moreau is a weak weak weak CEO.
Meanwhile, the question I'd ask is like a riddle or something.
The CEO thus far being flat out wrong in ALL of his rhetoric about what the market will do - should we look at it from the exact opposite?
Everybody wants out at Phase II but everybody wants in at Phase III?
As the AP story continues to play out (drip drip drip) you can bet the farm there will be lots of drama \|/ @ AP.
Market Data 
Markets 
AI
